Evidence map›Paper›PMID 42303865›Full record

ArticleEsophagus : official journal of the Japan Esophageal Society2026

Soft palate leukoplakia as an endoscopic finding associated with esophageal squamous cell carcinoma.

Kazuki Matsuyama, Ryu Ishihara, Kotaro Waki, Tomoya Ueda, Noriaki Ito, Nobutoshi Tsukuda, Muneshin Morita, Yoshiaki Ando, Yoshimi Tanaka, Minoru Kato and 6 more

Abstract read
PubMed Publisher
In one paragraph

Article in Esophagus : official journal of the Japan Esophageal Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Kazuki MatsuyamaDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-Ku, Osaka, 541-8567, Japan.
Ryu IshiharaDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-Ku, Osaka, 541-8567, Japan. ryu1486@gmail.com.ORCID http://orcid.org/0000-0002-8796-718X
Kotaro WakiDepartment of Gastroenterology and Hepatology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Tomoya UedaDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-Ku, Osaka, 541-8567, Japan.
Noriaki ItoDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-Ku, Osaka, 541-8567, Japan.
Nobutoshi TsukudaDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-Ku, Osaka, 541-8567, Japan.
Muneshin MoritaDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-Ku, Osaka, 541-8567, Japan.
Yoshiaki AndoDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-Ku, Osaka, 541-8567, Japan.
Yoshimi TanakaDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-Ku, Osaka, 541-8567, Japan.
Minoru KatoDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-Ku, Osaka, 541-8567, Japan.
Shunsuke YoshiiDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-Ku, Osaka, 541-8567, Japan.
Takashi KanesakaDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-Ku, Osaka, 541-8567, Japan.
Sachiko YamamotoDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-Ku, Osaka, 541-8567, Japan.
Koji HigashinoDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-Ku, Osaka, 541-8567, Japan.
Noriya UedoDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-Ku, Osaka, 541-8567, Japan.
Tomoki MichidaDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-Ku, Osaka, 541-8567, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe previously reported that specific endoscopic soft palate findings, including a whitish epithelium, were associated with esophageal squamous cell carcinoma (ESCC) history. In the present post hoc analysis of the same cohort, we re-evaluated endoscopic images to identify lesions corresponding to leukoplakia and further characterize their endoscopic features and clinical relevance in relation to ESCC.

methodsThis single-center retrospective study included 284 patients who underwent upper gastrointestinal endoscopy at the Osaka International Cancer Institute between January and May 2020. This analysis was based on the identical dataset used in our previous study. Associations between leukoplakia and an ESCC history were analyzed; moreover, the diagnostic performance was compared with conventional risk factors such as alcohol consumption, smoking, and flushing reactions.

resultsLeukoplakia was observed in 15.9% and 3.1% of the patients in the ESCC and non-ESCC groups (P < 0.01), respectively. The interobserver agreement for leukoplakia was substantial (κ = 0.71, 95% confidence interval: 0.56-0.86). Leukoplakia demonstrated a high specificity (96.9%) and a positive likelihood ratio of 5.21 for ESCC history, which were higher than for alcohol consumption and smoking. Leukoplakia was more easily evaluated using narrow band imaging/blue light imaging compared with white light imaging (P = 0.02).

conclusionsIn this post hoc analysis, soft palate leukoplakia was found to be an endoscopic finding associated with ESCC history, supporting the concept of field cancerization of the upper aerodigestive tract. Careful inspection of the soft palate during routine endoscopy may provide additional information for ESCC risk assessment, although prospective validation is warranted.

Indexed as

EpitheliumEsophageal squamous cell carcinomaLeukoplakiaPalateRisk factors

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.